These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35008527)

  • 41. Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells.
    Koo BS; Lee SH; Kim JM; Huang S; Kim SH; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    Oncogene; 2015 Apr; 34(18):2317-24. PubMed ID: 24954502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The oncogenic potential of NANOG: An important cancer induction mediator.
    Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
    J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
    Wang L; Guo H; Lin C; Yang L; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro.
    Kim YJ; Yuk N; Shin HJ; Jung HJ
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.
    Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R
    EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
    Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
    Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
    Kim D; Park M; Jang H; Hyun H; Lim W
    Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
    Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
    Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin treatment decreases the expression of cancer stem cell marker CD44 and stemness related gene expression in primary oral cancer cells.
    Patil S
    Arch Oral Biol; 2020 May; 113():104710. PubMed ID: 32208194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cisplatin induces stemness in ovarian cancer.
    Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
    Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines.
    Abdul Satar N; Ismail MN; Yahaya BH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysregulation of iron metabolism in cancer stem cells.
    Recalcati S; Gammella E; Cairo G
    Free Radic Biol Med; 2019 Mar; 133():216-220. PubMed ID: 30040994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
    Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
    Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
    Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
    Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
    Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
    Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.